We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INL:JSEInvestec Limited Analysis

Data as of 2026-03-16 - not real-time

ZAC 12,790.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Investec Group trades at ZAc 12,790, comfortably above its support of ZAc 12,501 but still below the 20‑day (ZAc 13,447), 50‑day (ZAc 13,235) and 200‑day (ZAc 12,955) moving averages, indicating short‑term weakness. The RSI sits at 38.5, hinting at mild oversold conditions, while the MACD line is deep in negative territory (-115.6) with a bearish signal, reinforcing downside pressure. On the valuation side, the stock’s PE ratio of 7.6 is well under the industry average of 16.35, suggesting earnings are cheap relative to peers, yet the price‑to‑book of 94.6 is extraordinarily high, reflecting a market premium that may be difficult to justify. The dividend yield of 6.92% and a payout ratio around 51% provide attractive income, supported by a strong cash balance (ZAc 12.15 bn) that more than doubles total debt (ZAc 6.26 bn). However, operating cash flow is negative (‑ZAc 0.33 bn), raising questions about cash‑flow sustainability. Volatility is elevated at roughly 21% over the past 30 days, but the beta of 0.22 signals low market‑wide price sensitivity. The market sentiment is exuberant, with the Fear & Greed Index at Extreme Greed, and the upside potential from the current price to the 52‑week high is modest at about 4.3%. Overall, the stock presents a mixed picture: cheap earnings and solid dividend income versus high valuation multiples and weak cash‑flow generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages
  • Bearish MACD and modest upside
  • High dividend yield supporting income

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE well below industry average
  • Strong cash position relative to debt
  • Attractive dividend with reasonable payout

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Low beta indicating defensive profile
  • Sustainable dividend income
  • Valuation balance between cheap earnings and high PB

Key Metrics & Analysis

Financial Health

Revenue Growth-0.60%
Profit Margin35.13%
P/E Ratio7.6
ROE12.09%
ROA1.18%
P/B Ratio94.6
Op. Cash FlowZAC-330670016
Industry P/E16.4

Technical Analysis

TrendBullish
RSI38.5
SupportZAC 12,501.00
ResistanceZAC 14,068.00
MA 20ZAC 13,447.30
MA 50ZAC 13,234.86
MA 200ZAC 12,955.42
MACDBearish
VolumeIncreasing
Fear & Greed Index76.46

Valuation

Target PriceZAC 13,340.94
Upside/Downside4.31%
GradeFair
TypeValue
Dividend Yield6.92%

Risk Assessment

Beta0.22
Volatility20.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.